Yan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yan Chen has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Hao Xu
Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
2 shared publications - Jinlong Li
Department of Orthopaedics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
2 shared publications - Li Zhang
Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China
2 shared publications - Lianping Xing
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA
2 shared publications - Qianqian Liang
Longhua Hospital, Shanghai University of Traditional Chinese Medicine , Shanghai
2 shared publications Boyu Zhang
Henan University of Chinese Medicine, Zhengzhou, China
1 shared publication
Latest Publications
- Open Access
- 31 October 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1669888
Efficacy of non-pharmacological interventions for alleviating insomnia in individuals with generalized anxiety disorder: systematic evaluation and net meta-analysis
Introduction: Anxiety is closely related to sleep, and the two often interact with each other. Generalized anxiety disorder (GAD) is often accompanied by insomnia, but pharmacologic interventions are typically ineffective and cause safety concerns. Despite the potential of non-pharmacological interventions (NIPs), their relative efficacy has not been clarified. The network meta-analysis (NMA) aims to explore the impact of NIPs on alleviating insomnia symptoms in patients with GAD. Methods and analysis: 24 randomized controlled trials (1,953 patients) evaluating 14 NIPs for GAD-related insomnia were utilized in this NMA. This study systematically searched the databases including PubMed, Web of Science, EMBASE, Cochran, CNKI, SinoMed, VIP, and Wanfang. Meanwhile, Bayesian method was employed in conjunction with Markov Chain Monte Carlo (MCMC) simulation. In addition, this study conducted statistical analyses by using R (version 4.4.1) and STATA (version 15.1). Interventions were ranked by standardized mean difference (SMD) and surface under the cumulative ranking curve (SUCRA); study quality was evaluated using the Cochrane Risk of Bias tool (ROB2.0). Sleep quality was assessed with Pittsburgh Sleep Quality Index (PSQI) as well as Insomnia Severity Index (ISI), and anxiety symptoms were measured using Hamilton Anxiety Scale (HAMA) and Self-rating Anxiety Scale (SAS). Results: Acupuncture (AC) showed the best efficacy in improving sleep quality and alleviating anxiety symptoms. The combination of transcranial magnetic stimulation with psychotherapy (TMS+PT) significantly improved sleep quality and alleviating anxiety symptoms. Other interventions (e.g., relaxation therapy, exercise therapy, etc.) had limited efficacy. Conclusion: AC and TMS+PT are the best NIPs to improve insomnia and relieve anxiety in GAD patients. In the future, conducting multicenter trials and in-depth mechanistic studies is expected to validate the efficacy and optimize the individualized treatment regimen. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/ , identifier, CRD420251010334.
- 31 October 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1669888
Open AccessEfficacy of non-pharmacological interventions for alleviating insomnia in individuals with generalized anxiety disorder: systematic evaluation and net meta-analysis
Introduction: Anxiety is closely related to sleep, and the two often interact with each other. Generalized anxiety disorder (GAD) is often accompanied by insomnia, but pharmacologic interventions are typically ineffective and cause safety concerns. Despite the potential of non-pharmacological interventions (NIPs), their relative efficacy has not been clarified. The network meta-analysis (NMA) aims to explore the impact of NIPs on alleviating insomnia symptoms in patients with GAD. Methods and analysis: 24 randomized controlled trials (1,953 patients) evaluating 14 NIPs for GAD-related insomnia were utilized in this NMA. This study systematically searched the databases including PubMed, Web of Science, EMBASE, Cochran, CNKI, SinoMed, VIP, and Wanfang. Meanwhile, Bayesian method was employed in conjunction with Markov Chain Monte Carlo (MCMC) simulation. In addition, this study conducted statistical analyses by using R (version 4.4.1) and STATA (version 15.1). Interventions were ranked by standardized mean difference (SMD) and surface under the cumulative ranking curve (SUCRA); study quality was evaluated using the Cochrane Risk of Bias tool (ROB2.0). Sleep quality was assessed with Pittsburgh Sleep Quality Index (PSQI) as well as Insomnia Severity Index (ISI), and anxiety symptoms were measured using Hamilton Anxiety Scale (HAMA) and Self-rating Anxiety Scale (SAS). Results: Acupuncture (AC) showed the best efficacy in improving sleep quality and alleviating anxiety symptoms. The combination of transcranial magnetic stimulation with psychotherapy (TMS+PT) significantly improved sleep quality and alleviating anxiety symptoms. Other interventions (e.g., relaxation therapy, exercise therapy, etc.) had limited efficacy. Conclusion: AC and TMS+PT are the best NIPs to improve insomnia and relieve anxiety in GAD patients. In the future, conducting multicenter trials and in-depth mechanistic studies is expected to validate the efficacy and optimize the individualized treatment regimen. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/ , identifier, CRD420251010334.
- Open Access
- 2 February 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-7
Effects of Golden Plaster on Knee Osteoarthritis: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial
Background. Golden plaster is the preferred and most commonly used in China for pain reduction in patients with knee osteoarthritis (OA). However, there was no evidence-based medical evidence about its effect in relieving pain of knee OA patients. Here, a multicenter randomized, double-blind, placebo-controlled trial was performed to evaluate the efficacy and safety of golden plaster for the improvement of pain relief and functions obstacle in patients with knee OA. Methods. 320 patients with knee OA were enrolled at four hospitals and randomly divided into the treatment group and the control group with 160 subjects in each group. Patients in treatment group were treated with golden plaster, and those in control group with placebo plaster. The study cycle in both groups was 21 days. Patient visits were documented before treatment and 7-, 14-, and 21-day follow-ups after treatment. The outcomes included VAS score, WOMAC score, and adverse events. Results. Compared to the control group, the VAS score in the treatment group was significantly decreased after treatment with golden plaster for 7 days, 14 days, and 21 days. Compared to the control group, the WOMAC score in the treatment group was significantly decreased 14 days and 21 days. The incidence rate of adverse events had no statistical difference between both the groups. Conclusions. In conclusion, our study, for the first time by carrying on the double-blind and placebo-controlled randomized trial, showed that golden plaster can effectively alleviate the pain of knee and improve the physical function in the patients with knee OA. This trial is registered with ChiCTR-TRC-13003418.
- 2 February 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-7
Open AccessEffects of Golden Plaster on Knee Osteoarthritis: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial
Background. Golden plaster is the preferred and most commonly used in China for pain reduction in patients with knee osteoarthritis (OA). However, there was no evidence-based medical evidence about its effect in relieving pain of knee OA patients. Here, a multicenter randomized, double-blind, placebo-controlled trial was performed to evaluate the efficacy and safety of golden plaster for the improvement of pain relief and functions obstacle in patients with knee OA. Methods. 320 patients with knee OA were enrolled at four hospitals and randomly divided into the treatment group and the control group with 160 subjects in each group. Patients in treatment group were treated with golden plaster, and those in control group with placebo plaster. The study cycle in both groups was 21 days. Patient visits were documented before treatment and 7-, 14-, and 21-day follow-ups after treatment. The outcomes included VAS score, WOMAC score, and adverse events. Results. Compared to the control group, the VAS score in the treatment group was significantly decreased after treatment with golden plaster for 7 days, 14 days, and 21 days. Compared to the control group, the WOMAC score in the treatment group was significantly decreased 14 days and 21 days. The incidence rate of adverse events had no statistical difference between both the groups. Conclusions. In conclusion, our study, for the first time by carrying on the double-blind and placebo-controlled randomized trial, showed that golden plaster can effectively alleviate the pain of knee and improve the physical function in the patients with knee OA. This trial is registered with ChiCTR-TRC-13003418.
- Open Access
- 1 October 2018
- Published by Elsevier in Journal of Traditional Chinese Medicine
- Vol. 38 (5) , 754-762
Pricking and penetrating moxibustion therapy in patients with refractory insomnia: a randomized and controlled clinical trial
- 1 October 2018
- Published by Elsevier in Journal of Traditional Chinese Medicine
- Vol. 38 (5) , 754-762
Open AccessPricking and penetrating moxibustion therapy in patients with refractory insomnia: a randomized and controlled clinical trial
- 1 December 2016
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 193, 293-302
Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells
- 1 December 2016
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 193, 293-302
Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells
- Open Access
- 12 March 2016
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 1-14
Lymphatic endothelial cells efferent to inflamed joints produce iNOS and inhibit lymphatic vessel contraction and drainage in TNF-induced arthritis in mice
In this study, we sought to determine the cellular source of inducible nitric oxide synthase (iNOS) induced in lymphatic endothelial cells (LECs) in response to tumor necrosis factor (TNF), the effects of iNOS on lymphatic smooth muscle cell (LSMC) function and on the development of arthritis in TNF-transgenic (TNF-Tg) mice, and whether iNOS inhibitors improve lymphatic function and reduce joint destruction in inflammatory erosive arthritis. We used quantitative polymerase chain reactions, immunohistochemistry, histology, and near-infrared imaging to examine (1) iNOS expression in podoplanin + LECs and lymphatic vessels from wild-type (WT) and TNF-Tg mice, (2) iNOS induction by TNF in WT LECs, (3) the effects of iNOS inhibitors on expression of functional muscle genes in LSMCs, and (4) the effects of iNOS inhibitors on lymphatic vessel contraction and drainage, as well as the severity of arthritis, in TNF-Tg mice. LECs from TNF-Tg mice had eight fold higher iNOS messenger RNA levels than WT cells, and iNOS expression was confirmed immunohistochemically in podoplanin + LECs in lymphatic vessels from inflamed joints. TNF (0.1 ng/ml) increased iNOS levels 40-fold in LECs. LSMCs cocultured with LECs pretreated with TNF had reduced expression of functional muscle genes. This reduction was prevented by ferulic acid, which blocked nitric oxide production. Local injection of L-N6-(1-iminoethyl)lysine 5-tetrazole-amide into inflamed paws of TNF-Tg mice resulted in recovery of lymphatic vessel contractions and drainage. Treatment of TNF-Tg mice with ferulic acid reduced synovial inflammation as well as cartilage and bone erosion, and it also restored lymphatic contraction and drainage. iNOS is produced primarily by LECs in lymphatic vessel efferent from inflamed joints of TNF-Tg mice in response to TNF and inhibits LSMC contraction and lymph drainage. Ferulic acid represents a potential new therapy to restore lymphatic function and thus improve inflammatory arthritis by inhibiting local production of nitric oxide by LSMCs.
- 12 March 2016
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 1-14
Open AccessLymphatic endothelial cells efferent to inflamed joints produce iNOS and inhibit lymphatic vessel contraction and drainage in TNF-induced arthritis in mice
In this study, we sought to determine the cellular source of inducible nitric oxide synthase (iNOS) induced in lymphatic endothelial cells (LECs) in response to tumor necrosis factor (TNF), the effects of iNOS on lymphatic smooth muscle cell (LSMC) function and on the development of arthritis in TNF-transgenic (TNF-Tg) mice, and whether iNOS inhibitors improve lymphatic function and reduce joint destruction in inflammatory erosive arthritis. We used quantitative polymerase chain reactions, immunohistochemistry, histology, and near-infrared imaging to examine (1) iNOS expression in podoplanin + LECs and lymphatic vessels from wild-type (WT) and TNF-Tg mice, (2) iNOS induction by TNF in WT LECs, (3) the effects of iNOS inhibitors on expression of functional muscle genes in LSMCs, and (4) the effects of iNOS inhibitors on lymphatic vessel contraction and drainage, as well as the severity of arthritis, in TNF-Tg mice. LECs from TNF-Tg mice had eight fold higher iNOS messenger RNA levels than WT cells, and iNOS expression was confirmed immunohistochemically in podoplanin + LECs in lymphatic vessels from inflamed joints. TNF (0.1 ng/ml) increased iNOS levels 40-fold in LECs. LSMCs cocultured with LECs pretreated with TNF had reduced expression of functional muscle genes. This reduction was prevented by ferulic acid, which blocked nitric oxide production. Local injection of L-N6-(1-iminoethyl)lysine 5-tetrazole-amide into inflamed paws of TNF-Tg mice resulted in recovery of lymphatic vessel contractions and drainage. Treatment of TNF-Tg mice with ferulic acid reduced synovial inflammation as well as cartilage and bone erosion, and it also restored lymphatic contraction and drainage. iNOS is produced primarily by LECs in lymphatic vessel efferent from inflamed joints of TNF-Tg mice in response to TNF and inhibits LSMC contraction and lymph drainage. Ferulic acid represents a potential new therapy to restore lymphatic function and thus improve inflammatory arthritis by inhibiting local production of nitric oxide by LSMCs.